Pediatric vaccines have virtually wiped out smallpox, polio and other deadly diseases in our lifetime. Today, pharmaceutical companies continue to pioneer advances in disease prevention — and our Pure-Flo MPC business is helping them get these miracle medicines to patients in less time.

Pure-Flo builds equipment used to produce vaccines and other drugs. Custom-engineered for biopharmaceutical clients, Pure-Flo’s process modules contain valves, pumps, vessels, filters and other equipment to ensure product quality and consistency.

Shipped to a new or expanded production facility, several of these train-size modules can be hooked up and inserted into a prebuilt shell to cut normal delivery time by three to six months. That means faster delivery to market for lifesaving vaccines.

To save biopharm clients even more vital time, Pure-Flo has developed an electronic format for storing and accessing the extensive documentation the government requires. After a new drug wins FDA approval, the equipment and processes used to make it must be certified as well.

The “Electronically Enhanced Turn Over Package” — or E2TOP — provides instant access to data on thousands of module parts. The information is more accurate, more comprehensive and better organized than the print manuals E2TOP replaces.

No other biopharm supplier offers anything comparable. Clients are impressed by its value-added capabilities.

“We’re ahead of the curve with E2TOP,” says Rick Kramer, commercial engineering manager for Pure-Flo Systems. “It has become a true source of differentiation with our customers.”